Skip to main content

Akebia Therapeutics, Inc 10-K for FY2023

Akebia Therapeutics, Inc. (AKBA)

10-K 2024-03-14 For: 2023-12-31
View Original
Added on April 11, 2026

About this 10-K

Akebia Therapeutics, Inc filed this 10-K on March 14, 2024, covering the fiscal year ended December 31, 2023 (FY2023).

Headline figures

Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$194.62M
down 33.5% from $292.48M a year earlier
Net loss
$51.93M
compared with a net loss of $94.23M a year earlier
Diluted EPS
-$0.28
compared with -$0.52 a year earlier